Stay informed with the latest litigation news. Explore now

University Of Washington Through Its Center For Commercialization competitive analysis

Latest publications and patents of University Of Washington Through Its Center For Commercialization New

Explore the latest publications and patents granted to University Of Washington Through Its Center For Commercialization, showcasing their recent innovations and technological advancements.

Last updated on: Sep 2, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of University Of Washington Through Its Center For Commercialization

Jul 19, 2023Hla Class Ii Deficient Cells, Hla Class I Deficient Cells Capable Of Expressing Hla Class Ii Proteins, And Uses ThereofGranted And Under Opposition
Apr 7, 2021Methods Of Lowering The Error Rate Of Massively Parallel Dna Sequencing Using Duplex Consensus SequencingGranted And Under Opposition
Nov 4, 2020Beta-2 Microglobulin-Deficient CellsPatent Maintained As Amended

Explore University Of Washington Through Its Center For Commercialization's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 19, 2023Hla Class Ii Deficient Cells, Hla Class I Deficient Cells Capable Of Expressing Hla Class Ii Proteins, And Uses Thereof2
Apr 7, 2021Methods Of Lowering The Error Rate Of Massively Parallel Dna Sequencing Using Duplex Consensus Sequencing3
Nov 4, 2020Beta-2 Microglobulin-Deficient Cells1

Latest PTAB cases involving University Of Washington Through Its Center For Commercialization New

Discover the latest PTAB cases involving University Of Washington Through Its Center For Commercialization, highlighting their recent legal challenges and patent disputes.

Top competitors of University Of Washington Through Its Center For Commercialization

Top competitors of University Of Washington Through Its Center For Commercialization based on patent oppositions.